Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessCase report

Visceral leishmaniasis with cardiac involvement in a dog: a case report

Mónica López-Peña1 email, Nuria Alemañ2 email, Fernando Muñoz1 email, Dolors Fondevila3 email, María Luisa Suárez1 email, Ana Goicoa1 email and Jose María Nieto1 email

Hospital Clínico Veterinario Rof Codina, Dpto. Ciencias Clínicas Veterinarias, Universidade de Santiago de Compostela, Spain

Dpto. de Anatomía y Producción Animal, Facultade de Veterinaria de Lugo, Universidade de Santiago de Compostela, Spain

Dpt. Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Spain

author email corresponding author email

Acta Veterinaria Scandinavica 2009, 51:20doi:10.1186/1751-0147-51-20

Published: 30 April 2009

Abstract

A dog presented with cutaneous nodules, enlarged lymph nodes and oedema in limbs, face and abdomen. The diagnosis of visceral leishmaniasis was established by identification of Leishmania amastigotes within macrophages from skin and popliteal lymph node biopsies. At necropsy, lesions were found in different organs, but it was particularly striking to observe large areas of pallor in the myocardium. Histological examination revealed an intense chronic inflammatory reaction in many organs, and numerous macrophages were found to contain amastigote forms of Leishmania. The inflammatory reaction was especially severe in the heart, where large areas of the myocardium appeared infiltrated with huge numbers of mononuclear immune cells, causing cardiac muscle atrophy and degeneration. Despite the severe inflammation, the number of parasitized macrophages was low in the myocardium, as revealed by immunohistochemical staining of Leishmania amastigotes. Because cardiac involvement is not usually described in this condition, this dog represents a very rare case of canine visceral leishmaniasis with affection of the myocardium.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.